Systa Pharma Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.00 Cr
- Company Age 36 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 3.70 M
- Revenue Growth -97.16%
- Profit Growth -49.32%
- Ebitda -122.34%
- Net Worth -75.07%
- Total Assets -4.22%
About Systa Pharma Labs
Systa Pharma Labs Private Limited (SPLPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 December 1988 and has a history of 36 years and one month. Its registered office is in Thrissur, Kerala, India.
The Corporate was formerly known as Chethana Drugs And Chemicals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company has closed loans amounting to ₹3.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Variketta Namboodiri, Vijayasree, and Bhat Sambhu serve as directors at the Company.
Company Details
-
Location
Thrissur, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231KL1988PTC005263
-
Company No.
005263
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Dec 1988
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Systa Pharma Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijayasree
|
Managing Director | 25-Jan-2010 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Variketta Namboodiri
|
Director | 25-Jan-2010 | Current |
|
Bhat Sambhu
|
Director | 15-Dec-2009 | Current |
Financial Performance of Systa Pharma Labs.
Systa Pharma Labs Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 97.16% decrease. The company also saw a substantial fall in profitability, with a 49.32% decrease in profit. The company's net worth observed a substantial decline by a decrease of 75.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Systa Pharma Labs?
In 2020, Systa Pharma Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Penta Labs Private LimitedVariketta Namboodiri, Vijayasree and 1 more are mutual person
-
Vintanova Pharma Private Limited
Variketta Namboodiri, Vijayasree and 1 more are mutual person
Charges (Loans)
₹0
₹0.37 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 0.37 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jan 2002 | Canara Bank | ₹1.60 M | Satisfied |
| 17 Nov 1995 | Canara Bank | ₹2.00 M | Satisfied |
| 17 Nov 1995 | Canara Bank | ₹0.10 M | Satisfied |
How Many Employees Work at Systa Pharma Labs?
Unlock and access historical data on people associated with Systa Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Systa Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Systa Pharma Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
